コーパス検索結果 (left1)
通し番号をクリックするとPubMedの該当ページを表示します
2 ent at bivalent promoters in ground-state 2i mESCs, is necessary, but not sufficient, to establish th
4 d the gene expression profile of embryo- and mESC-derived CPCs and CMs at different developmental sta
7 mechanisms may not yet be fully developed as mESCs express lower levels of IFN-stimulated genes and d
9 compared control and ERbeta knockout (BERKO) mESCs at defined stages of neural development and examin
10 scripts are differentially expressed between mESCs and mEpiSCs and that these genes show expected cha
13 at perturbing cell-secreted signaling causes mESCs to exit their stable self-renewing state in define
14 fferentiation competency of the Cdk2ap1(-/-) mESCs was restored upon the ectopic expression of Cdk2ap
15 ing and modulates mouse embryonic stem cell (mESC) differentiation in part through deacetylation of c
16 the analysis of murine embryonic stem cell (mESC) differentiation in vitro in response to inducers o
17 is study, we used mouse embryonic stem cell (mESC) differentiation to uncover a new mechanism for PI3
18 n three syngeneic mouse embryonic stem cell (mESC) lines: htt(-/-), extended poly-Q (Htt-Q140/7), and
21 anisms regulating mouse embryonic stem cell (mESC) self-renewal and lineage differentiation, we have
22 ar foundations of mouse embryonic stem cell (mESC) self-renewal by applying a proven Bayesian network
24 edium-throughput murine embryonic stem cell (mESC)-based high-content screening of 17000 small molecu
27 fferentiation of mouse embryonic stem cells (mESC) into neural lineages, we compared control and ERbe
33 unction study in mouse embryonic stem cells (mESCs) and identified 20 lincRNAs involved in the mainte
37 ly reported that mouse embryonic stem cells (mESCs) are deficient in expressing type I interferons (I
39 opmental stages, mouse embryonic stem cells (mESCs) are resistant to cell fate conversion induced by
40 We have measured mouse embryonic stem cells (mESCs) at different states during differentiation (t=0h,
41 ipotent state of mouse embryonic stem cells (mESCs) by enabling LIF-dependent STAT3 phosphorylation,
42 ve reported that mouse embryonic stem cells (mESCs) can be selectively induced in vitro to differenti
43 ion of Nup153 in mouse embryonic stem cells (mESCs) causes the derepression of developmental genes an
47 Studies with mouse embryonic stem cells (mESCs) demonstrated an increase in overall beta(1,3)gala
50 fferentiation of mouse embryonic stem cells (mESCs) generates a population with many of the propertie
52 embryos and from mouse embryonic stem cells (mESCs) have primarily been studied within a cell populat
53 e we "stressed" murine embryonic stem cells (mESCs) in vitro with epinephrine (EPI) during their adip
54 cient to convert mouse embryonic stem cells (mESCs) into 2-cell-embryo-like ('2C-like') cells, measur
55 terconversion of mouse embryonic stem cells (mESCs) is a valuable in vitro model for early embryonic
56 fferentiation of mouse embryonic stem cells (mESCs) is accompanied by changes in replication timing.
57 A methylation in mouse embryonic stem cells (mESCs) lacking the de novo DNA methyltransferases (Dnmts
59 t3/4 (Pou5f1) in mouse embryonic stem cells (mESCs) maintained under standard culture conditions to g
60 pluripotency in mouse embryonic stem cells (mESCs) relies on the activity of a transcriptional netwo
64 apping of 5fC in mouse embryonic stem cells (mESCs) reveals that 5fC preferentially occurs at poised
65 gene editing in mouse embryonic stem cells (mESCs) to produce mice with targeted gene disruptions an
66 The ability of mouse embryonic stem cells (mESCs) to self-renew or differentiate into various cell
68 pluripotency of mouse embryonic stem cells (mESCs) was extracted from several ChIP-Seq and knockdown
69 fferentiation of mouse embryonic stem cells (mESCs), and is particularly high in the promoter regions
70 II) promoters in mouse embryonic stem cells (mESCs), and this activity correlates with CpG islands.
71 OG expression in mouse embryonic stem cells (mESCs), and to dissect the lineage potential of mESCs at
73 of Brca2(cko/ko) mouse embryonic stem cells (mESCs), carrying a null (ko) and a conditional (cko) all
74 d PRC2-deficient mouse embryonic stem cells (mESCs), demonstrating an H3K27me3-independent pathway fo
75 re, we show that mouse embryonic stem cells (mESCs), either lacking Tet3 alone or with triple deficie
77 ansduce, such as mouse embryonic stem cells (mESCs), human ESCs (hESCs), and induced pluripotent stem
78 3) substrates in mouse embryonic stem cells (mESCs), providing a broad profile of GSK-3 activity and
80 on self-renewing mouse embryonic stem cells (mESCs), where shear stresses varying by >1000 times (0.0
82 nal regulator of mouse embryonic stem cells (mESCs), Yin-yang 2 (YY2), that is controlled by the tran
97 e fabricated by encapsulating pure mESC-CMs, mESC-CMs + adult CFs, or mESC-CMs + fetal CFs in fibrin-
98 r efficient derivation of germline-competent mESCs from any mouse strain, including strains previousl
99 nhancing Brf1 expression does not compromise mESC pluripotency but does preferentially regulate mesen
100 then integrated these data into a consensus mESC functional relationship network focused on biologic
101 rated that STAT3 activation and consequently mESC fate were manipulable by flow rate, position in the
102 ing of the regulatory topology that controls mESC fate decisions as well as to develop robust directe
108 scription is up-regulated in differentiating mESCs and that chemical inhibition of beta-catenin/TCF1
110 expression dynamics of retinoic acid driven mESC differentiation from pluripotency to lineage commit
111 involved in germ layer specification during mESC differentiation in a cooperative and redundant fash
112 ce of a saturated soluble environment (i.e., mESC-conditioned medium), we ascertained that flow-induc
113 elopmental pluripotency state to the earlier mESC-like pluripotency state, providing new insights int
114 e endoderm cells of which cognate embryonic (mESCs) or extra-embryonic (XEN) stem cell lines can be d
116 The results suggest that Icaritin enhances mESCs self-renewal by regulating cell cycle machinery an
117 ole of Myc in the maintenance of murine ESC (mESC) pluripotency through the regulation of a set of mi
118 (BMP4) is sufficient to maintain mouse ESCs (mESCs) in a self-renewing state, this does not preclude
120 mined the potential of EXT1(-/-) mouse ESCs (mESCs), that are deficient in HS, to differentiate into
121 endogenous Fgf4, which is necessary to exit mESC self-renewal, but not for XEN cell maintenance.
122 P4 is more prone to degradation in EXT1(-/-) mESCs culture medium compared with that of wild type cel
124 NANOG fluctuations provide opportunities for mESCs to explore multiple lineage options, modulating th
129 ingle cell gene expression measurements from mESCs cultured in serum/LIF or serum-free 2i/LIF conditi
130 medium or threonine dehydrogenase (Tdh) from mESCs decreased accumulation of SAM and decreased trimet
134 fluorescence microscopy of intact H1DeltaTKO mESC demonstrated both a loss of nucleolar RNA content a
136 extensive metabolic aberrations in htt(-/-) mESCs, including (i) complete failure of ATP production
138 Gli2 protein was heterogeneously detected in mESC nuclei by immunofluorescence microscopy and this re
142 y, the functions of the affected proteins in mESC closely overlapped with those of the human T cell n
144 a complex interplay between Tet1 and Tet2 in mESC, and to distinct roles for these two proteins in re
150 erting methionine to S-adenosylmethionine in mESCs, methionine adenosyltransferase 2a (MAT2a), is und
154 the presence of two active X chromosomes in mESCs prevents exit from pluripotency by blocking MAPK s
155 Taken together, a deletion of Cited2 in mESCs results in abnormal mitochondrial morphology and i
163 scriptional activity of Oct3/4 fluctuates in mESCs and that Oct3/4 plays an essential role in sustain
164 nisms associated with E-cadherin function in mESCs is compounded by the difficulty in delineating the
165 the effects of type I IFNs are functional in mESCs; however, these mechanisms may not yet be fully de
170 ngly, these loci are enriched for H3K9me3 in mESCs, implicating this mark in DNA methylation homeosta
171 MSL is the main HAT acetylating H4K16 in mESCs, is enriched at many mESC-specific and bivalent ge
173 lf2 expression can replace Mek inhibition in mESCs, allowing the culture of Klf2-null mESCs under Gsk
174 he metabolism of glucose was investigated in mESCs, which contained a deletion in the gene for Cited2
175 can induce dsRNA-activated protein kinase in mESCs, and this activation resulted in a strong inhibiti
178 RYBP-PRC1 is recruited to target loci in mESCs and is also involved in Xist RNA-mediated silencin
179 omotes the persistence of DNA methylation in mESCs, likely reflecting one mechanism by which DNA meth
180 iated crosstalk between lncRNAs and mRNA, in mESCs, is thus surprisingly prevalent, conserved in mamm
181 huttles between the cytoplasm and nucleus in mESCs but accumulates in the cytoplasm in an inactive fo
182 to promote self-renewal and pluripotency in mESCs partly by opposing MAPK/ERK-mediated differentiati
184 pathway showed unique expression profiles in mESCs and validated this observation by RT-PCR analysis.
188 C, or NC2 by anchor away in yeast or RNAi in mESCs leads to near-identical transcriptome phenotypes,
190 to keep a subset of bivalent genes silent in mESCs, while developmental genes require MSL for express
191 ted sequencing of 295 dCas9 binding sites in mESCs transfected with catalytically active Cas9 identif
192 transition from Lewis(x)-type structures in mESCs to sialylated Galbeta1,3GalNAc-type glycans on dif
194 deletion, RNAi-mediated depletion of Tet1 in mESCs led to a significant reduction in 5hmC and loss of
195 ating a transgenic system we exhibit that in mESCs, the pluripotency master regulator Oct4, counterac
199 chastic NANOG fluctuations are widespread in mESCs, with essentially all expressing cells showing flu
204 f MAPK/ERK signaling, both known to maintain mESCs in the absence of LIF, rescued Tet1 depletion, fur
208 n-regulated gene in Zbtb24 homozygous mutant mESCs, which can be restored by ectopic ZBTB24 expressio
209 nctions of DGCR8, we complemented the mutant mESCs with a phosphomutant DGCR8, which restored microRN
210 mental potential of low-NANOG and high-NANOG mESCs, grown in different conditions, and confirm that m
212 STAT3 phosphorylation, with E-cadherin null mESCs exhibiting over 3000 gene transcript alterations a
216 udy, we assembled an extensive compendium of mESC data: approximately 2.2 million data points, collec
217 vely, our studies show that 3D co-culture of mESC-CMs with embryonic CFs is superior to co-culture wi
218 g NKG2D in vitro resulted in less killing of mESC by allogeneic NK cells, indicating NKG2D is a likel
220 revealing a previously undescribed level of mESC regulation through the use of microfluidic perfusio
222 we conclude that YY2 is a major regulator of mESC self-renewal and lineage commitment and document a
225 Here, we report that small aggregates of mESCs, of about 300 cells, self-organise into polarised
226 triggered in three-dimensional aggregates of mESCs, the population self-organizes macroscopically and
227 data support the conclusion that analysis of mESCs in the hours/days immediately following efficient
228 h adherent and three-dimensional cultures of mESCs to probe the establishment and maintenance of NMps
229 ency factor in the proper differentiation of mESCs by modulating the phosphorylation level of pRb.
247 these findings suggest that the potential of mESCs includes the capacity to give rise to both extra-e
248 ent unique and uncharacterized properties of mESCs and are important for understanding innate immunit
249 ere, we report single cell RNA-sequencing of mESCs cultured in three different conditions: serum, 2i,
251 ed teratomas indistinguishable from those of mESCs, and underwent efficient osteogenic differentiatio
258 with DNA methylation heterogeneity, p53(-/-) mESCs display increased cellular heterogeneity both in t
259 lation imbalance in p53-deficient (p53(-/-)) mESCs is the result of augmented overall DNA methylation
260 e not present in 2i ground-state pluripotent mESCs but appear upon their further development into pri
262 ole of paracrine signaling, we cultured pure mESC-CMs within miniature tissue "micro-patches" supplem
263 atches were fabricated by encapsulating pure mESC-CMs, mESC-CMs + adult CFs, or mESC-CMs + fetal CFs
265 YY2 plays a critical role in regulating mESC functions through control of key pluripotency facto
266 t that beta-catenin's function in regulating mESCs is highly context specific and that its interactio
267 This study demonstrates that self-renewing mESCs possess the molecular machinery to sense shear str
274 fferent developmental stages and showed that mESC-derived CMs are phenotypically similar to embryo-de
276 wn in different conditions, and confirm that mESCs are more susceptible to enter differentiation at t
280 g (with heparin) HSPG function, we show that mESCs also mechanically sense shear stress via HSPGs to
285 However, full conversion of EpiSCs to the mESC-like state with chimerism competence could be readi
289 at Tet1 targets, ultimately contributing to mESC differentiation and the onset of embryonic developm
290 matic morphological changes in EpiSCs toward mESC phenotypes with simultaneous activation of inner ce
293 Proteomic profiling of purified wild-type mESC nucleoli identified a total of 613 proteins, only ~
294 extended poly-Q (Htt-Q140/7), and wild-type mESCs (Htt-Q7/7) using untargeted metabolite profiling.
296 that fluctuations have similar kinetics when mESCs are cultured in standard conditions (serum plus le
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。